| 摘要 |
The use of estrone or derivatives of estrone, equilin, or equilenin, including pharmaceutically acceptable salts, as well as pharmaceutical compositions comprising these compounds as a therapeutic agent in humans or in animals is claimed. The asserted use is as an antiemetic agent or for the treatment of other disorders that can be ameliorated by noncompetitive antagonism of the 5-hydroxytryptamine type 3 receptor.
|
